Context Capital Management, LLC - Q1 2017 holdings

$125 Million is the total value of Context Capital Management, LLC's 45 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 43.8% .

 Value Shares↓ Weighting
BuyTTM TECHNOLOGIES INCnote 1.750%12/1$10,637,000
+113.1%
6,020,000
+84.1%
8.50%
+55.5%
 LGI HOMES INCnote 4.250%11/1$9,386,000
+15.1%
5,693,0000.0%7.50%
-16.0%
 PDL BIOPHARMA INCnote 2.750%12/0$7,546,000
+7.8%
8,575,0000.0%6.03%
-21.4%
BuyCARRIAGE SVCS INCnote 2.750% 3/1$6,523,000
+60.9%
5,000,000
+66.7%
5.22%
+17.4%
BuySOLARCITY CORPnote 1.625%11/0$6,425,000
+309.5%
7,189,000
+287.3%
5.14%
+198.8%
BuyAPOLLO COML REAL EST FIN INCnote 5.500% 3/1$6,220,000
+418.3%
5,670,000
+392.6%
4.97%
+278.2%
NewTESLA INCnote 1.250% 3/0$5,892,0006,000,000
+100.0%
4.71%
SellENDOLOGIX INCnote 3.250%11/0$5,504,000
-47.9%
5,575,000
-54.1%
4.40%
-62.0%
SellSPECTRUM PHARMACEUTICALS INCnote 2.750%12/1$4,564,000
-29.5%
4,469,000
-36.6%
3.65%
-48.6%
BuyTOLL BROS FIN CORPnote 0.500% 9/1$4,276,000
+324.6%
4,298,000
+320.1%
3.42%
+210.0%
NewCHESAPEAKE ENERGY CORPnote 5.500% 9/1$4,153,0004,000,000
+100.0%
3.32%
SellCTRIP COM INTL LTDnote 1.000% 7/0$3,883,000
-5.4%
3,500,000
-12.5%
3.10%
-31.0%
BuyENCORE CAP GROUP INCnote 3.000% 7/0$3,683,000
+37.0%
3,865,000
+34.9%
2.94%
-0.0%
SellALBANY MOLECULAR RESH INCnote 2.250%11/1$3,637,000
-47.4%
3,325,000
-37.6%
2.91%
-61.6%
BuyTHERAVANCE BIOPHARMA INCnote 3.250%11/0$3,180,000
+83.8%
2,500,000
+66.7%
2.54%
+34.1%
BuyPANDORA MEDIA INCnote 1.750%12/0$2,999,000
+483.5%
3,000,000
+500.0%
2.40%
+325.9%
NewCONVERGYS CORPsdcv 5.750% 9/1$2,972,0001,500,000
+100.0%
2.38%
NewKEYW HLDG CORPnote 2.500% 7/1$2,903,0003,000,000
+100.0%
2.32%
SellINTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$2,804,000
-32.8%
3,000,000
-35.5%
2.24%
-51.0%
NewVERISIGN INCsdcv 3.250% 8/1$2,554,0001,000,000
+100.0%
2.04%
BuyACORDA THERAPEUTICS INCnote 1.750% 6/1$2,547,000
+123.4%
3,000,000
+100.0%
2.04%
+63.0%
SellSILVER STD RES INCnote 2.875% 2/0$2,208,000
-12.6%
2,250,000
-18.2%
1.76%
-36.3%
BuyVECTOR GROUP LTDnote 1.750% 4/1$2,061,000
+59.5%
1,817,000
+63.5%
1.65%
+16.4%
BuyIGI LABORATORIES INCnote 3.750%12/1$2,005,000
+332.1%
2,000,000
+300.0%
1.60%
+215.6%
NewDEPOMED INCnote 2.500% 9/0$1,884,0002,000,000
+100.0%
1.51%
NewTWO HBRS INVT CORPnote 6.250% 1/1$1,795,0001,750,000
+100.0%
1.44%
SPY  SPDR S&P 500 ETF TRtr unit$1,768,000
+5.5%
7,5000.0%1.41%
-23.0%
VTI  VANGUARD INDEX FDStotal stk mkt$1,698,000
+5.2%
14,0000.0%1.36%
-23.2%
BuyARBOR RLTY TR INCnote 6.500%10/0$1,579,000
+58.2%
1,500,000
+50.0%
1.26%
+15.5%
BuySEACOR HOLDINGS INCnote 2.500%12/1$1,526,000
+47.2%
1,500,000
+50.0%
1.22%
+7.4%
SellALLEGHENY TECHNOLOGIES INCnote 4.750% 7/0$1,263,000
-75.6%
850,000
-77.9%
1.01%
-82.2%
AAPL  APPLE INC$1,250,000
+24.0%
8,7000.0%1.00%
-9.5%
SellAEGERION PHARMACEUTICALS INCnote 2.000% 8/1$1,221,000
-56.9%
1,500,000
-61.6%
0.98%
-68.5%
NewNEW MTN FIN CORPnote 5.000% 6/1$836,000808,000
+100.0%
0.67%
KLRE NewKLR ENERGY ACQUISITION CORPcl a$724,00070,138
+100.0%
0.58%
NewTESLA INCnote 2.375% 3/1$519,000500,000
+100.0%
0.42%
 COBALT INTL ENERGY INCnote 2.625%12/0$340,000
-15.2%
1,000,0000.0%0.27%
-38.0%
 COBALT INTL ENERGY INCnote 3.125% 5/1$119,000
-18.5%
500,0000.0%0.10%
-40.6%
ExitSPDR S&P 500 ETF TRput$0-150
-100.0%
-0.00%
ExitWEATHERFORD INTL LTDnote 5.875% 7/0$0-1,000,000
-100.0%
-1.19%
ExitTCP CAP CORPnote 5.250%12/1$0-1,118,000
-100.0%
-1.28%
ExitSOLARCITY CORPnote 2.750%11/0$0-3,833,000
-100.0%
-3.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
THERAVANCE BIOPHARMA INC23Q2 20224.7%
ENCORE CAPITAL GROUP INC19Q2 20196.2%
INTERCEPT PHARMACEUTICALS IN18Q4 20226.2%
INFINERA CORPORATION18Q1 20233.6%
TESLA MTRS INC16Q1 20194.9%
DISH NETWORK CORPORATION16Q3 20233.3%
ENDOLOGIX INC15Q2 201911.6%
OMEROS CORP15Q3 20233.1%
VANGUARD TOTAL STOCK MKT ETF15Q1 20203.9%
AMAG PHARMACEUTICALS INC14Q3 20207.7%

View Context Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Context Capital Management, LLC Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ELECTRO ENERGY INCFebruary 17, 2009326,1244.9%
IRONCLAD PERFORMANCE WEAR CORPSold outFebruary 17, 200900.0%
Jazz Technologies, Inc.Sold outFebruary 17, 200900.0%
VELOCITY EXPRESS CORPFebruary 17, 2009190,1045.3%
ATS CORPJune 17, 2008723,0733.6%
Ascend Acquisition Corp.Sold outJune 16, 200800.0%
HIGHBURY FINANCIAL INCSold outJune 16, 200800.0%
PRIMUS TELECOMMUNICATIONS GROUP INCSold outJune 16, 200800.0%
Good Harbor Partners Acquisition CorpSold outFebruary 13, 200800.0%
InfuSystem Holdings, IncFebruary 13, 2008152,3500.8%

View Context Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-02
SCHEDULE 13G2024-03-20
13F-HR/A2024-02-16
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-08
13F-HR2023-02-14
13F-HR2022-11-07
13F-HR2022-08-03

View Context Capital Management, LLC's complete filings history.

Compare quarters

Export Context Capital Management, LLC's holdings